Wellington Management Group
AZN icon

Wellington Management Group’s AstraZeneca AZN Stock Holding History

Wellington Management Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-632
Closed -$702K – 2199
2017
Q4 		$702K Buy
632
+194
+44% +$13.1K ﹤0.01% 1983
2017
Q3 		$473K Buy
+438
New +$27.7K ﹤0.01% 2051

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group's AZN Position: Q1 2026 in Review

Wellington Management Group increased its AstraZeneca (AZN) stake by 108% in Q1 2026, buying an estimated $2.38B and bringing the position to 23,751,085 shares worth $4.63B. The position accounts for 0.86% of the portfolio, ranked #13.

Wellington Management Group first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Wellington Management Group held 23,751,085 shares of AstraZeneca worth $4.63B as of Q1 2026.
  • Wellington Management Group bought 12,336,962 AstraZeneca shares in Q1 2026, an estimated $2.38B.
  • AstraZeneca made up 0.86% of Wellington Management Group's portfolio in Q1 2026, its #13 holding.
  • Wellington Management Group first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.